Peroxisome proliferator-activated receptor-δ activation ameliorates albuminuria by preventing nephrin loss and restoring podocyte integrity in Type 2 diabetes

Nephrology Dialysis Transplantation

Volumn 27, Issue 11, 2012, Pages 4069-4079

  Lee, Eun Young ^a   Kim, Geun Tae ^a   Hyun, Miri ^a   Kim, Suji ^a   Seok, Sujin ^a   Choi, Ran ^b   Lee, Mi Young ^b   Chung, Choon Hee ^b  

^a Soonchunhyang University College of Medicine   (South Korea)

^b Yonsei University Wonju   (South Korea)

Author keywords

albuminuria; diabetic nephropathy; nephrin; podocyte; PPAR

Indexed keywords

DESMIN; GLUCOSE; GW 610742; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEPHRIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA AGONIST; UNCLASSIFIED DRUG;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; GLOMERULUS BASEMENT MEMBRANE; HUMAN; HUMAN TISSUE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION;

ALBUMINURIA; ANIMALS; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; PODOCYTES; PPAR GAMMA; RATS; RATS, INBRED OLETF; REAL-TIME POLYMERASE CHAIN REACTION; THIAZOLES;

EID: 84869472895     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs358     Document Type: Article

References (25)

1. Feige JN, Gelman L, Michalik L et al. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Prog Lipid Res 2006; 45:120-159. (Pubitemid 43248732)
2. Ruan X, Zheng F, Guan Y. PPARs and the kidney in metabolic syndrome. Am J Physiol Renal Physiol 2008; 294: F1032-F1047.
3. Mukundan L, Odegaard JI, Morel CR et al. PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance. Nat Med 2009; 15:1266-1272.
4. Letavernier E, Perez J, Joye E et al. Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure. J Am Soc Nephrol 2005; 16:2395-2402. (Pubitemid 41725057)
5. Miglio G, Rosa AC, Rattazzi L et al. The subtypes of peroxisome proliferator-activated receptors expressed by human podocytes and their role in decreasing podocyte injury. Br J Pharmacol 2011; 162:111-125.
6. Hao CM, Redha R, Morrow J et al. Peroxisome proliferator activated receptor delta activation promotes cell survival following hypertonic stress. J Biol Chem 2002; 277:21341-21345. (Pubitemid 34952273)
7. Proctor G, Jiang T, Iwahashi M et al. Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes 2006; 55:2502-2509. (Pubitemid 44871150)
8. Berfield AK, Chait A, Oram JF et al. IGF-1 induces rat glomerular mesangial cells to accumulate triglyceride. Am J Physiol Renal Physiol 2006; 290: F138-F147.
9. Winzell MS, Wulff EM, Olsen GS et al. Improved insulin sensitivity and islet function after PPARdelta activation in diabetic db/db mice. Eur J Pharmacol 2010; 626:297-305.
10. Van der Veen JN, Kruit JK, Havinga R et al. Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1. J Lipid Res 2005; 46:526-534. (Pubitemid 43109789)
11. Sznaidman ML, Haffner CD, Maloney PR et al. Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta-synthesis and biological activity. Bioorg Med Chem Lett 2003; 13:1517-1521. (Pubitemid 36428550)
12. Lane PH, Steffes MW, Mauer SM. Estimation of glomerular volume: a comparison of four methods. Kidney Int 1992; 41:1085-1089.
13. Lee EY, Lee MY, Hong SW et al. Blockade of oxidative stress by vitamin C ameliorates albuminuria and renal sclerosis in experimental diabetic rats. Yonsei Med J 2007; 48:847-855. (Pubitemid 350130477)
14. Wang A, Ziyadeh FN, Lee EY et al. Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclero-sis without affecting albuminuria. Am J Physiol Renal Physiol 2007; 293: F1657-F1665. (Pubitemid 350086003)
15. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37:911-917.
16. Gross ML, Adamczak M, Rabe T et al. Beneficial effects of estrogens on indices of renal damage in uninephrectomized SHRsp rats. J Am Soc Nephrol 2004; 15:348-358. (Pubitemid 38140775)
17. Lee EY, Chung CH, Kim JH et al. Antioxidants ameliorate the expression of vascular endothelial growth factor mediated by protein kinase C in diabetic podocytes. Nephrol Dial Transplant 2006; 21:1496-1503. (Pubitemid 44063123)
18. Lee EY, Chung CH, Khoury CC et al. The monocyte chemoattrac-tant protein-1/CCR2 loop, inducible by TGF-β, increases podocyte motility and albumin permeability. Am J Physiol Renal Physiol 2009; 297: F85-F94.
19. Fan SC, Yu BC, Chen ZC et al. The decreased expression of peroxi-some proliferator-activated receptors delta is reversed by digoxin in the heart of diabetic rats. Horm Metab Res 2010; 42:637-642.
20. Matsushita Y, Ogawa D, Wada J et al. Activation of peroxisome pro-liferator-activated receptor delta inhibits streptozotocin-induced diabetic nephropathy through anti-inflammatory mechanisms in mice. Diabetes 2011; 60:960-968.
21. Cohen MP, Chen S, Ziyadeh FN et al. Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, protei-nuria, and diabetic nephropathy. Kidney Int 2005; 68:1554-1561. (Pubitemid 43169900)
22. Lin CL, Wang FS, Hsu YC et al. Modulation of notch-1 signaling alleviates vascular endothelial growth factor-mediated diabetic nephropathy. Diabetes 2010; 59:1915-1925.
23. Benigni A, Zoja C, Tomasoni S et al. Transcriptional regulation of nephrin gene by peroxisome proliferator-activated receptor-y agonist: molecular mechanism of the antiproteinuric affect of piogli-tazone. J Am Soc Nephrol 2006; 17:1624-1632. (Pubitemid 43794665)
24. Ren S, Xin C, Beck KF et al. PPARoc activation upregulates nephrin expression in human embryonic kidney epithelial cells and podo-cytes by a dual mechanism. Biochem Biophys Res Commun 2005; 338:1818-1824. (Pubitemid 41643096)
25. Takata Y, Liu J, Yin F et al. PPARô-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis. Proc Natl Acad Sci USA 2008; 105:4277-4282. (Pubitemid 351754371)